Validation and testing of the Russian version of PHPQoL questionnaire for quality of life assessment in patients with primary hyperparathyroidism (PHPT)

Background: Quality of life (QoL) assessment before and after surgical treatment in patients with primary hyperparathyroidism (PHTP) may be useful for comprehensive evaluation of the treatment effect, as well as for monitoring of the patient’ condition after surgery, including in real clinical practice.

Aim: The aim of the study was to validate and test the Russian version of the PHPQoL questionnaire for assessment of the quality of life (QoL) in patients with primary hyperparathyroidism (PHPT) for further application in clinical practice and research in Russia.

Materials and methods: The linguistic and cultural adaptation of the PHPQoL questionnaire was carried out in accordance with international guidelines. Psychometric properties of the tool, namely, its reliability, validity and sensitivity were tested in the focus group of patients with PHPT

Results: In the whole, 65 patients with PHPT were involved into the study (mean age — 52.3 ± 10.5 years, 97% — ­women): 67.7% patients were symptomatic, 35.4% patients had moderate or severe hypercalcemia. All the patients filled out the Russian version of PHPQoL before parathyroidectomy. One third of patients filled out the Russian version of PHPQoL twice — before surgery and 3 months after surgery. Satisfactory external and content validity of the Russian version of PHPQoL was demonstrated. Its stable structure confirmed satisfactory construct validity of the questionnaire. The ability of the tool to determine differences in severity of symptoms/problems due to PHPT before and after treatment was revealed. The positive effect of the surgery on QoL in PHPT patients was shown.

Conclusion: The results obtained during the study confirm that the Russian version of PHPQoL is a reliable, valid and sensitive tool. Feasibility and applicability of its use in research and clinical practice in Russian endocrinology settings has been demonstrated.

1. Klinicheskie rekomendatsii Rossiiskoi assotsiatsii endokrinologov. Pervichnyi giperparatireoz. Ministerstvo zdravookhraneniya RF. M.; 2016. (In Russ.).

2. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151(10):959. doi: https://doi.org/10.1001/jamasurg.2016.2310

3. Hyperparathyroidism (primary): diagnosis, assessment and initial management. NICE guideline Published: 23 May 2019. Available for: https://www.nice.org.uk/guidance/ng132

4. Roman S, Sosa JA. Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr Opin Oncol. 2007;19(1):1-5. doi: https://doi.org/10.1097/CCO.0b013e32801173fb

5. Mokrysheva NG, Krupinova YuA, Bibik EE, Melnichenko GA. Cognitive impairment in primary hyperparathyroidism. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(1):103-108. (In Russ.). doi: https://doi.org/10.14412/2074-2711-2019-1-103-108

6. Pasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: A 10-year prospective surgical outcome study. Surgery. 2009;146(6):1006-1013. doi: https://doi.org/10.1016/j.surg.2009.10.021

7. Bilezikian JP, Khan AA and Potts Jr JT. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab. 2009;94(2):335-339. doi: https://doi.org/10.1210/jc.2008-1763

8. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2009;99(10):3561-9. doi: https://doi.org/10.1210/jc.2014-1413

9. Adler JT, Sippel RS, Schaefer S, Chen H. Surgery improves quality of life in patients with «mild» hyperparathyroidism. Am J Surg. 2009;197(3):284-290. doi: https://doi.org/10.1016/j.amjsurg.2008.09.009

10. Brito K, Edirimanne S, Eslick GD. The extent of improvement of health-related quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism – A systematic review and meta-analysis. Int J Surg. 2015;13:245-249. doi: https://doi.org/10.1016/j.ijsu.2014.12.004

11. Caillard C, Sebag F, Mathonnet M, et al. Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery. 2007;141(2):153-160. doi: https://doi.org/10.1016/j.surg.2006.12.004

12. Murray SE, Pathak PR, Schaefer SC, et al. Improvement of Sleep Disturbance and Insomnia Following Parathyroidectomy for Primary Hyperparathyroidism. World J Surg. 2014;38(3):542-548. doi: https://doi.org/10.1007/s00268-013-2285-1

13. Coker LH, Rorie K, Cantley L, et al. Primary Hyperparathyroidism, Cognition, and Health-Related Quality of Life. Ann Surg. 2005;242(5):642-650. doi: https://doi.org/10.1097/01.sla.0000186337.83407.ec

14. Webb SM, Puig-Domingo M, Villabona C, et al. Development of a new tool for assessing Health-Related Quality of Life in patients with primary hyperparathyroidism. Health Qual Life Outcomes. 2013;11(1):97. doi: https://doi.org/10.1186/1477-7525-11-97

15. Webb SM, Puig-Domingo M, Villabona C, et al. Validation of PHPQoL, a Disease-Specific Quality-of-Life Questionnaire for Patients With Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2016;101(4):1571-1578. doi: https://doi.org/10.1210/jc.2015-3094

16. Somuncu E, Kara Y. The effect of parathyroidectomy on quality of life in primary hyperparathyroidism: evaluation with using sf-36 and phpqol questionnaire. Endocr J. 2020. doi: https://doi.org/10.1507/endocrj.EJ20-0417

17. Guidelines for Best Practice in Cross-Cultural Surveys. 2016. 842 р.

18. Nikitina TP, Gladkova IN, Efremov SM, et al. Razrabotka russkoy versii oprosnika PHPQoL dlya otsenki katchestva zshizni u patsientov s pervichnym giperparatireozom. (Conference proceedings). XXIX Rossiyskii simpozium po endokrinnoi khirurgii s utchastiem endokrinologov «Kalininskie chtenia»; 2019, 25-26 October; Kazan. Р. 59-60. (In Russ.).

19. Ryhänen E, Heiskanen I, Sintonen H, et al. Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument. Endocrine Connections. 2015;4(3):179-186.

20. Ejlsmark-Svensson H, Sikjaer T, Webb SM, et al. Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study. Clin Endocrinol (Oxf). 2019;90(1):184-191. doi: https://doi.org/10.1111/cen.13865